<?xml version="1.0" encoding="UTF-8"?>
<p id="Par91">Both subcutaneous (SCIT) and sublingual (SLIT) immunotherapy can be continued during the current COVID-19 pandemic, in all asymptomatic patients, in healthy children with negative test results, without exposure or recent contact with subjects symptomatic or virus-positive or who have not recently traveled to high-risk areas. In particular, immunotherapy for Hymenoptera venom (SCIT for bee, wasp, and bumblebee) must be regularly administered, is a life-saving drug. Venom immunotherapy is a life-saving treatment to prevent anaphylaxis, as is effective in 100% of the subjects treated [
 <xref ref-type="bibr" rid="CR67">67</xref>]. Venom therapy could avoid single-use of adrenaline.
</p>
